J M Oli1, P J Watkins, B Wild, O J Adegoke. 1. Department of Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria. joli@infoweb.abs.net
Abstract
AIMS: To determine the prevalence of albuminuria [raised albumin-creatinine ratio (ACR)] in an out-patient population of Afro-Caribbeans with Type 2 diabetes mellitus (DM) and to determine if the possession of the sickle cell trait (SCT) is a risk factor. PATIENTS AND METHODS: The ACR in a morning urine sample was determined in each of 181 Afro-Caribbeans with Type 2 DM attending the out-patient clinic at King's Diabetes Centre of King's College Hospital, London. The subjects were genotyped for the SCT, Haemoglobin AS (HbAS). RESULTS: Although a raised ACR was demonstrated more frequently in those with the SCT than in those without, with an odds ratio of 1.19, this was not statistically significant (P = 0.68). CONCLUSIONS: In this study the possession of the SCT does not appear to play a significant role in the development of albuminuria. However, a larger study is needed to clarify its role as a risk factor for development of albuminuria in Afro-Caribbeans with Type 2 DM.
AIMS: To determine the prevalence of albuminuria [raised albumin-creatinine ratio (ACR)] in an out-patient population of Afro-Caribbeans with Type 2 diabetes mellitus (DM) and to determine if the possession of the sickle cell trait (SCT) is a risk factor. PATIENTS AND METHODS: The ACR in a morning urine sample was determined in each of 181 Afro-Caribbeans with Type 2 DM attending the out-patient clinic at King's Diabetes Centre of King's College Hospital, London. The subjects were genotyped for the SCT, Haemoglobin AS (HbAS). RESULTS: Although a raised ACR was demonstrated more frequently in those with the SCT than in those without, with an odds ratio of 1.19, this was not statistically significant (P = 0.68). CONCLUSIONS: In this study the possession of the SCT does not appear to play a significant role in the development of albuminuria. However, a larger study is needed to clarify its role as a risk factor for development of albuminuria in Afro-Caribbeans with Type 2 DM.
Authors: Jonathan C Goldsmith; Vence L Bonham; Clinton H Joiner; Gregory J Kato; Allan S Noonan; Martin H Steinberg Journal: Am J Hematol Date: 2012-02-03 Impact factor: 10.047
Authors: Anthony J Bleyer; Sri V Reddy; Leon Sujata; Gregory B Russell; Damilola Akinnifesi; Anthony J Bleyer; Donald Hire; Zak Shihabi; Mary Ann Knovich; Pirouz Daeihagh; Jorge Calles; Barry I Freedman Journal: Clin J Am Soc Nephrol Date: 2010-03-18 Impact factor: 8.237
Authors: Pamela J Hicks; Carl D Langefeld; Lingyi Lu; Anthony J Bleyer; Jasmin Divers; Patrick H Nachman; Vimal K Derebail; Donald W Bowden; Barry I Freedman Journal: Kidney Int Date: 2011-08-17 Impact factor: 10.612
Authors: Caroline K Thoreson; Michelle Y O'Connor; Madia Ricks; Stephanie T Chung; Anne E Sumner Journal: J Racial Ethn Health Disparities Date: 2015-09
Authors: Rakhi P Naik; Kim Smith-Whitley; Kathryn L Hassell; Nkeiruka I Umeh; Mariane de Montalembert; Puneet Sahota; Carlton Haywood; Jean Jenkins; Michele A Lloyd-Puryear; Clinton H Joiner; Vence L Bonham; Gregory J Kato Journal: Ann Intern Med Date: 2018-10-30 Impact factor: 25.391